Dr. Nimisha Srivastava Appointed Chief Executive Officer to Lead Slingshot Bio into Its Next Chapter
Slingshot Biosciences, a leader in precision-engineered cell mimics for flow cytometry, announced that Dr. Nimisha Srivastava has been appointed Chief...
California Life Sciences Statement on AB 1776, the California COMPETE Act
California’s antitrust laws must take into account the impact the life sciences sector has had in our state and around...
Governor Gavin Newsom has signed AB 1887 into law — a critical step forward for California’s rare disease community. This...
iNFixion seeks NF1 treatment by enhancing what the body is doing right
Since discovering his daughter’sNF1, a rare disease impacting 1 in 3000 people, nearly 25 years ago, Sarnoff has slowly transformed...
BrainStorm Therapeutics combines brain organoids and AI for CNS drug discovery
Artificial intelligence is opening new possibilities for drug discovery. But in neuroscience, AI is only as powerful as the biological...
Otsuka Pharmaceutical Development & Commercialization, Inc. and Ionis Pharmaceuticals, Inc. today announced positive topline results from the Phase 3 FUSION...
In celebration of Health Simulation Week (September 14-18), we are excited to introduce the Clinical Readiness Studio (CRS), an AI-augmented...
OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform...
Avance Clinical Appoints Inaugural Chief Commercial Officer, Reinforcing Global Growth Strategy
Avance Clinical, a global full-service CRO headquartered in Australia dedicated to servicing international biotechs, today announced the appointment of Tim...